Einar Marius Hjellestad Martinsen

Einar Marius Hjellestad Martinsen

Auto-generated profile, based on publicly available information

Einar Marius Hjellestad Martinsen

Affiliation Department of Clinical Science, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in European Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
ELElise Orvedal Leiten
Elise Orvedal Leiten
EMEinar Marius Hjellestad Martinsen
Einar Marius Hjellestad Martinsen
PBPer Sigvald Bakke
Per Sigvald Bakke
TETomas M. Eagan
Tomas M. Eagan
RGRune Grønseth
Rune Grønseth
Complications and discomfort of bronchoscopy: a systematic review

1 July 2017 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
RGRune Grønseth
Rune Grønseth
CDChristine Drengenes
Christine Drengenes
HWHarald G. Wiker
Harald G. Wiker
STSolveig Tangedal
Solveig Tangedal
YXYaxin Xue
Yaxin Xue
TETomas M. Eagan
Tomas M. Eagan
The aim was to evaluate susceptibility of oropharyngeal contamination with various bronchoscopic sampling techniques.67 patients with obstructive lung disease and 58 control subjects underwent bronchoscopy with small-volume lavage (SVL) through the working channel, protected bronchoalveolar lavage (PBAL) and bilateral protected specimen brush (PSB) sampling. Subjects also provided an oral wash (OW) sample, and negative control samples were gathered for each bronchoscopy procedure. DNA encoding bacterial 16S ribosomal RNA was sequenced and bioinformatically processed to cluster into operational taxonomic units (OTU), assign taxonomy and obtain measures of diversity.The proportion of Proteobacteria increased, whereas Firmicutes diminished in the order OW, SVL, PBAL, PSB (p<0.01). The alpha-diversity decreased in the same order (p<0.01). Also, beta-diversity varied by sampling method (p<0.01), and visualisation of principal coordinates analyses indicated that differences in diversity were smaller between OW and SVL and OW and PBAL samples than for OW and the PSB samples. The order of sampling (leftversusright first) did not influence alpha- or beta-diversity for PSB samples.Studies of the airway microbiota need to address the potential for oropharyngeal contamination, and protected sampling might represent an acceptable measure to minimise this problem.

7 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EMEinar M. H. Martinsen
Einar M. H. Martinsen
TETomas M. L. Eagan
Tomas M. L. Eagan
ELElise O. Leiten
Elise O. Leiten
IHIngvild Haaland
Ingvild Haaland
GHGunnar R. Husebø
Gunnar R. Husebø
RNRune Nielsen
Rune Nielsen
Background: The fungal part of the pulmonary microbiome (mycobiome) is understudied. We report the composition of the oral and pulmonary mycobiome in participants with COPD compared to controls in a large-scale single-centre bronchoscopy study (MicroCOPD). Methods: Oral wash and bronchoalveolar lavage (BAL) was collected from 93 participants with COPD and 100 controls. Fungal DNA was extracted before sequencing of the internal transcribed spacer 1 (ITS1) region of the fungal ribosomal RNA gene cluster. Taxonomic barplots were generated, and we compared taxonomic composition, Shannon index, and beta diversity between study groups, and by use of inhaled steroids. Results: The oral and pulmonary mycobiomes from controls and participants with COPD were dominated by Candida, and there were more Candida in oral samples compared to BAL for both study groups. Malassezia and Sarocladium were also frequently found in pulmonary samples. No consistent differences were found between study groups in terms of differential abundance/distribution. Alpha and beta diversity did not differ between study groups in pulmonary samples, but beta diversity varied with sample type. The mycobiomes did not seem to be affected by use of inhaled steroids. Conclusion: Oral and pulmonary samples differed in taxonomic composition and diversity, possibly indicating the existence of a pulmonary mycobiome.

1 January 2014 in European Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
RGRune Grønseth
Rune Grønseth
IHIngvild Haaland
Ingvild Haaland
HWHarald G. Wiker
Harald G. Wiker
EMEinar Marius H. Martinsen
Einar Marius H. Martinsen
ELElise O. Leiten
Elise O. Leiten
TETomas M. Eagan
Tomas M. Eagan
The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences

1 July 2020 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
ELElise Orvedal Leiten
Elise Orvedal Leiten
RNRune Nielsen
Rune Nielsen
HWHarald Gotten Wiker
Harald Gotten Wiker
PBPer Sigvald Bakke
Per Sigvald Bakke
EMEinar Marius Hjellestad Martinsen
Einar Marius Hjellestad Martinsen
TETomas Mikal Lind Eagan
Tomas Mikal Lind Eagan
Aim: The aim of this study was to investigate whether the compositionality of the lower airway microbiota predicts later exacerbation risk in persons with COPD in a cohort study.Materials and methods: We collected lower airways microbiota samples by bronchoalveolar lavage and protected specimen brushes, and oral wash samples from 122 participants with COPD. Bacterial DNA was extracted from all samples, before we sequenced the V3-V4 region of the 16S RNA gene. The frequency of moderate and severe COPD exacerbations was surveyed in telephone interviews and in a follow-up visit. Compositional taxonomy and α and β diversity were compared between participants with and without later exacerbations.Results: The four most abundant phyla were Firmicutes, Bacteroidetes, Proteobacteria and Fusobacteria in both groups, and the four most abundant genera wereStreptococcus,Veillonella,PrevotellaandGemella. The relative abundances of different taxa showed a large variation between samples and individuals, and no statistically significant difference of either compositional taxonomy, or α or β diversity could be found between participants with and without COPD exacerbations within follow-up.Conclusion: The findings from the current study indicate that individual differences in the lower airway microbiota in persons with COPD far outweigh group differences between frequent and nonfrequent COPD exacerbators, and that the compositionality of the microbiota is so complex as to present large challenges for use as a biomarker of later exacerbations.

1 January 2016 in European Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
EMEinar Marius Hjellestad Martinsen
Einar Marius Hjellestad Martinsen
ELElise Orvedal Leiten
Elise Orvedal Leiten
PBPer Sigvald Bakke
Per Sigvald Bakke
TETomas M. Eagan
Tomas M. Eagan
RGRune Grønseth
Rune Grønseth
Participation in research bronchoscopy: a literature review